Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

Investigational Site Number 056001, Leuven

Investigational Site Number 056003, Namur

Investigational Site Number 056002, Haine-Saint-Paul

Investigational Site Number 056005, Kortrijk

Investigational Site Number 203001, Prague

Investigational Site Number 250004, Caen

Investigational Site Number 380004, Genova

Investigational Site Number 380003, Milan

Investigational Site Number 724003, Madrid

Investigational Site Number 724001, Madrid

Investigational Site Number 840009, Atlanta

Investigational Site Number 250006, Bordeaux

Investigational Site Number 840202, Fort Meyers

Investigational Site Number 804003, Dnipropetrovsk

Investigational Site Number 804004, Kharkiv

Investigational Site Number 250001, Lyon

Investigational Site Number 804002, Lviv

Investigational Site Number 203003, Nový Jičín

Investigational Site Number 250002, Paris

Investigational Site Number 203004, Zlín

Investigational Site Number 203002, Olomouc

Investigational Site Number 276001, München

Investigational Site Number 804005, Donetsk

Investigational Site Number 840007, Burbank

Investigational Site Number 250003, Villejuif

Investigational Site Number 643002, Moscow

Investigational Site Number 643003, Moscow

Investigational Site Number 643001, Moscow

Investigational Site Number 643004, Saint Petersburg

Investigational Site Number 840001, New Haven

Investigational Site Number 840002, Boston

Investigational Site Number 380001, Roma

Investigational Site Number 616002, Krakow

Investigational Site Number 616004, Poznan

Investigational Site Number 616003, Rybnik

Investigational Site Number 616005, Warsaw

Investigational Site Number 616001, Warsaw

Investigational Site Number 724002, Barcelona